# A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes

> **NCT07124208** · NA · RECRUITING · sponsor: **First Institute of All Medicines** · enrollment: 46 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** Biophoton Generators

## Key facts

- **NCT ID:** NCT07124208
- **Lead sponsor:** First Institute of All Medicines
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-08
- **Primary completion:** 2026-08-15
- **Final completion:** 2026-08-15
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07124208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07124208, "A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07124208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*